Pharsight

Adcetris patents expiration

List of large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US7090843 NA Recombinant anti-CD30 antibodies and uses thereof
Aug, 2023

(25 days ago)

US7829531 NA Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
Jun, 2024

(8 months from now)

Ingredients: BRENTUXIMAB

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic